Transplantation-a medical miracle of the 20th century, N Engl J Med, vol.351, pp.2678-2680, 2004. ,
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: Randomised comparison of two cyclosporin regimens, Lancet, vol.351, pp.623-628, 1998. ,
Immunosuppressive drugs for kidney transplantation, N Engl J Med, vol.351, pp.2715-2729, 2004. ,
Diagnosis and prevention of chronic kidney allograft loss, Lancet, vol.378, pp.1428-1437, 2011. ,
The natural history of chronic allograft nephropathy, N Engl J Med, vol.349, pp.2326-2333, 2003. ,
Strategies to improve long-term outcomes after renal transplantation, N Engl J Med, vol.346, pp.580-590, 2002. ,
Controlling the incidence of infection and malignancy by modifying immunosuppression, Transplantation, vol.72, pp.89-93, 2001. ,
Risk of neoplasia in renal transplant patients, Lancet, vol.346, pp.403-406, 1995. ,
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: The CAESAR Study, Am J Transplant, vol.7, pp.560-570, 2007. ,
Reduced exposure to calcineurin inhibitors in renal transplantation, N Engl J Med, vol.357, pp.2562-2575, 2007. ,
Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study, J Am Soc Nephrol, vol.16, pp.2234-2240, 2005. ,
Sirolimus Renal Function Study G. Improved renal function in sirolimustreated renal transplant patients after early cyclosporine elimination, Transplantation, vol.74, pp.1560-1567, 2002. ,
15-year follow-up of a multicenter, randomized, calcineurin inhibitor withdrawal study in kidney transplantation, Transplantation, vol.98, pp.47-53, 2014. ,
Open randomized trial comparing early withdrawal of either cyclosporine or mycophenolate mofetil in stable renal transplant recipients initially treated with a triple drug regimen, J Am Soc Nephrol, vol.13, pp.536-543, 2002. ,
Frequency and impact of nonadherence to immunosuppressants after renal transplantation: A systematic review, Transplantation, vol.15, pp.769-776, 2004. ,
Long-term outcomes after cyclosporine or mycophenolate withdrawal in kidney transplantation-Results from an aborted trial, Clin Transplant, vol.27, pp.151-156, 2013. ,
Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: A randomized, prospective, multicenter study, J Am Soc Nephrol, vol.13, pp.1365-1373, 2002. ,
Two hundred living donor kidney transplantations under alemtuzumab induction and tacrolimus monotherapy: 3-year follow-up, Am J Transplant, vol.9, pp.355-366, 2009. ,
Multicenter trial exploring calcineurin inhibitors avoidance in renal transplantation, Transplantation, vol.71, pp.1282-1287, 2001. ,
Long-term clinical impact of adaptation of initial tacrolimus dosing to CYP3A5 genotype, Am J Transplant, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01296771
A meta-analysis of immunosuppression withdrawal trials in renal transplantation, J Am Soc Nephrol, vol.11, pp.1910-1917, 2000. ,
Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients, Clin Transplant, vol.26, pp.428-437, 2012. ,
Loss of pediatric kidney grafts during the "high-risk age window": Insights from pediatric liver and simultaneous liver-kidney recipients, Am J Transplant, vol.15, pp.445-452, 2015. ,
Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation, Transplantation, vol.84, pp.1215-1219, 2007. ,
Biomarkers and possible mechanisms of operational tolerance in kidney transplant patients, Immunol Rev, vol.258, pp.208-217, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02163167
Adverse outcomes of tacrolimus withdrawal in immune-quiescent kidney transplant recipients, J Am Soc Nephrol, vol.26, pp.3114-3122, 2015. ,
Differing effects of rapamycin or calcineurin inhibitor on T-regulatory cells in pediatric liver and kidney transplant recipients, Am J Transplant, vol.12, pp.3449-3461, 2012. ,
Safe conversion from tacrolimus to belatacept in high immunologic risk kidney transplant recipients with allograft dysfunction, Am J Transplant, vol.15, pp.2726-2731, 2015. ,
Belatacept and long-term outcomes in kidney transplantation, N Engl J Med, vol.374, pp.333-343, 2016. ,
Through a glass darkly: Seeking clarity in preventing late kidney transplant failure, J Am Soc Nephrol, vol.26, pp.20-29, 2015. ,